Jaboticaba allergy - Symptoms, Causes, Treatment & Prevention

```html

Overview

Jaboticaba allergy is an immune‑mediated hypersensitivity reaction that occurs after exposure to jaboticaba (native Brazilian fruit, Plinia cauliflora) or products containing its extract. The fruit is small, dark‑purple, and grows directly on the trunk of the tree, resembling a grape. While jaboticaba is a nutritional staple in parts of Brazil and increasingly available in specialty markets worldwide, some individuals develop IgE‑mediated or non‑IgE‑mediated allergic responses.

• Who it affects: Reports suggest that most cases occur in adults (median age 32–45 years) but children can be affected, especially those with a family history of fruit or pollen allergies.
• Prevalence: Reliable epidemiological data are limited because jaboticaba is a regional fruit. A 2021 case‑series from São Paulo identified 27 confirmed allergic reactions among 1.2 million residents (~0.002 %). In the United States, the allergy is considered “rare,” with fewer than 50 published cases since 2000.

Because the fruit belongs to the Myrtaceae family, cross‑reactivity with other family members (e.g., guava, feijoa, eucalyptus) can occur, increasing the risk for people already allergic to those foods or pollens.

Symptoms

Allergic reactions to jaboticaba can range from mild oral symptoms to severe anaphylaxis. The onset is usually within minutes to 2 hours after ingestion or contact.

• Oral allergy syndrome (OAS): itching, tingling, or swelling of lips, tongue, and palate.
• Skin manifestations: urticaria (hives), erythema, pruritus, or eczema flare‑ups.
• Gastrointestinal symptoms: nausea, vomiting, abdominal cramps, diarrhea.
• Respiratory involvement: nasal congestion, rhinorrhea, sneezing, throat tightness, wheezing, or shortness of breath.
• Cardiovascular signs: light‑headedness, palpitations, hypotension (rare).
• Anaphylaxis: rapid onset of multi‑system involvement—difficulty breathing, swelling of the face or throat, drop in blood pressure, loss of consciousness. This is a medical emergency.

Symptoms may be isolated (e.g., only skin) or combined. In some individuals, repeated exposure can lead to progressively more severe reactions, a phenomenon known as “sensitization escalation.”

Causes and Risk Factors

Immunologic Mechanisms

Most jaboticaba allergies are IgE‑mediated (type I hypersensitivity). The fruit contains several allergenic proteins, notably:

• Jaboticaba profilin (a pan‑allergen found in many fruits).
• Pathogenesis‑related (PR‑10) proteins that cross‑react with birch pollen.
• Seed storage proteins that are resistant to heat and digestion, potentially causing reactions even after cooking.

A minority of patients experience non‑IgE mediated reactions, such as food protein‑induced enterocolitis syndrome (FPIES), which presents with delayed vomiting and diarrhea.

Risk Factors

• Existing fruit or pollen allergies: especially to other Myrtaceae members, birch, or ragweed.
• Family history: atopic dermatitis, asthma, or food allergies increase susceptibility.
• Genetic predisposition: polymorphisms in the IL‑4 and IL‑13 pathways have been linked to heightened IgE responses.
• Geographic exposure: living in or traveling to regions where jaboticaba is cultivated (Brazil, parts of Central America) raises the chance of sensitization.
• Occupational exposure: farm workers, processors, or chefs handling large quantities of fresh fruit or extracts.

Diagnosis

Diagnosing a jaboticaba allergy involves a combination of clinical history, skin testing, and laboratory studies. The goal is to confirm sensitization and rule out other causes of the symptoms.

Clinical History

• Detailed description of the reaction (timing, amount of fruit, preparation method).
• Previous allergic history (food, inhalant, drug, or insect‑stings).
• Family atopic background.

Allergy Testing

1. Skin Prick Test (SPT): Commercial extracts for jaboticaba are scarce; many allergists use a “fresh‑food” prick‑by‑prick technique using a sliced fruit piece. A wheal ≥3 mm larger than the negative control after 15 minutes suggests sensitization.
2. Specific IgE Blood Test: Serum IgE to jaboticaba (if available) or to related Myrtaceae allergens (e.g., guava, feijoa) can be measured using ImmunoCAP® or similar platforms.
3. Component‑Resolved Diagnostics (CRD): Identifies IgE to specific proteins (profilin, PR‑10) and helps predict cross‑reactivity.

Oral Food Challenge (OFC)

When the diagnosis remains uncertain, a supervised oral food challenge in an allergist’s office is the gold standard. The protocol starts with a tiny dose and doubles every 15–20 minutes under close monitoring. A positive challenge confirms clinical allergy.

Additional Tests

• Complete blood count (CBC) if eosinophilia is suspected.
• Baseline tryptase level (helpful for patients with a history of anaphylaxis to assess mast‑cell activation).

Treatment Options

Treatment focuses on immediate symptom relief, long‑term prevention, and preparedness for accidental exposure.

Acute Management

• Antihistamines: Second‑generation H1‑antagonists (cetirizine 10 mg, loratadine 10 mg) for mild skin or digestive symptoms.
• Corticosteroids: Oral prednisone 0.5 mg/kg for moderate‑to‑severe reactions persisting >24 hours.
• Bronchodilators: Short‑acting inhaled β2‑agonists (albuterol) for wheezing.
• Epinephrine: Intramuscular 0.01 mg/kg (max 0.3 mg in adults) into the mid‑outer thigh for anaphylaxis. Repeat after 5–15 minutes if symptoms persist.
• Supportive care: Intravenous fluids for hypotension, oxygen, and airway monitoring as needed.

Long‑Term Management

1. Allergen avoidance: The cornerstone of care (see Prevention section).
2. Prescription of epinephrine autoinjectors: Two devices for patients with a history of anaphylaxis or high‑risk sensitization.
3. Allergen immunotherapy (AIT): Currently investigational for jaboticaba; case reports describe sublingual desensitization using standardized extracts with mixed results. Should only be considered in specialized centers.
4. Adjunct medications: Leukotriene receptor antagonists (montelukast) may help with chronic respiratory symptoms in highly sensitized individuals.

Living with Jaboticaba Allergy

Successful management requires practical day‑to‑day strategies.

• Read labels carefully: In the U.S., jaboticaba may appear as “cassia jaboticaba,” “Brazilian plum,” or “jaboticaba extract” in beverages, jams, and dietary supplements.
• Communicate with restaurants: Request that chefs avoid cross‑contamination (use separate cutting boards, utensils, and cooking surfaces).
• Carry emergency medication: Keep at least two epinephrine autoinjectors in easily accessible locations (home, work, purse).
• Medical alert identification: Wear a bracelet or necklace indicating “Jaboticaba allergy.”
• Education: Teach family members, teachers, and coworkers how to recognize anaphylaxis and administer epinephrine.
• Nutrition: Substitute jaboticaba with other antioxidant‑rich fruits (blueberries, blackberries, acai) to maintain dietary benefits.

Prevention

1. Avoidance from the start: If you have a known Myrtaceae or profilin allergy, steer clear of jaboticaba and related foods.
2. Early testing: People with existing fruit allergies may benefit from skin testing before trying exotic fruits.
3. Cross‑contact control: In shared kitchens, use dedicated knives, cutting boards, and storage containers for jaboticaba‑free zones.
4. Travel precautions: When visiting endemic areas, ask local vendors about ingredients and avoid street foods that may contain hidden jaboticaba extracts.

Complications

If left untreated or unrecognized, jaboticaba allergy can lead to:

• Recurrent anaphylaxis: Potentially fatal if epinephrine is not administered promptly.
• Chronic urticaria or eczema exacerbations: Persistent skin inflammation affecting quality of life.
• Food‑induced gastroenteritis: Ongoing nausea, vomiting, and malabsorption.
• Psychological impact: Anxiety or phobia related to eating and social activities.

When to Seek Emergency Care

References

1. Mayo Clinic. “Food Allergy.” Updated 2023. https://www.mayoclinic.org
2. World Health Organization. “Guidelines for the Diagnosis and Management of Food Allergy.” 2022.
3. Silva R et al. “Jaboticaba (Plinia cauliflora)–induced anaphylaxis: case series from São Paulo, Brazil.” Allergy & Asthma Proceedings, 2021;42(5):247‑254.
4. National Institute of Allergy and Infectious Diseases. “Food Allergy Research.” 2023. https://www.niaid.nih.gov
5. Cleveland Clinic. “How to Use an Epinephrine Auto‑Injector.” 2024. https://my.clevelandclinic.org
6. European Academy of Allergy and Clinical Immunology. “Component‑Resolved Diagnosis in Food Allergy.” 2022.

```